ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,044Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 1107

$1M Total Retail Price of All Prescriptions

Rank: 93 out of 1107

426 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 10,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 757 410 1 5
LISINOPRIL 691 402 2 2
METFORMIN HCL 601 349 3 8
HYDROCHLOROTHIAZIDE 551 341 4 11
OMEPRAZOLE 513 285 5 4
HYDROCODONE-ACETAMINOPHEN 398 260 S3 6 1
AMLODIPINE BESYLATE 373 204 7 6
POTASSIUM CHLORIDE 373 254 7 14
GABAPENTIN 363 186 9 9
NEXIUM 363 192 9 18
RANITIDINE HCL 329 166 11 21
FUROSEMIDE 303 173 12 7
ATENOLOL 285 188 13 19
CRESTOR 285 159 13 23
TRAMADOL HCL 260 107 15 26
SYNTHROID 255 161 16 70
ZOLPIDEM TARTRATE 240 99 17 22
LEVOTHYROXINE SODIUM 230 158 18 3
METOPROLOL TARTRATE 229 131 19 10
ATORVASTATIN CALCIUM 227 171 20 13
ISOSORBIDE MONONITRATE ER 208 132 21 34
CLOPIDOGREL 174 101 22 28
TIZANIDINE HCL 166 45 23 73
GLYBURIDE 159 121 R 24 68
PRAVASTATIN SODIUM 158 109 25 12
SERTRALINE HCL 156 72 26 20
JANUVIA 154 87 27 60
LANTUS 144 69 28 49
TAMSULOSIN HCL 140 95 29 30
PLAVIX 139 84 30 39
CYMBALTA 130 54 31 50
ATENOLOL-CHLORTHALIDONE 128 98 32 189
SINGULAIR 127 65 33 65
CARVEDILOL 126 60 34 27
MELOXICAM 126 60 34 25
PROAIR HFA 124 62 36 37
QUINAPRIL HCL 121 79 37 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 67 38 24
ACETAMINOPHEN-CODEINE 115 61 S3 39 120
PANTOPRAZOLE SODIUM 109 74 40 30
ZETIA 108 59 41 76
AZITHROMYCIN 107 58 42 35
MECLIZINE HCL 106 79 43 114
AMITRIPTYLINE HCL 105 75 R 44 48
IBUPROFEN 104 30 45 63
ROPINIROLE HCL 103 61 46 69
SUCRALFATE 102 36 47 121
TRAMADOL HCL-ACETAMINOPHEN 101 67 48 195
METOPROLOL SUCCINATE 97 62 49 16
AVODART 93 77 50 204
ADVAIR DISKUS 93 46 50 54
ALLOPURINOL 92 46 52 36
SYMBICORT 92 36 52 124
PAROXETINE HCL 92 31 52 45
LEVOCETIRIZINE DIHYDROCHLORIDE 91 70 55 203
LOVAZA 81 56 56 101
CELEBREX 79 62 57 85
SPIRONOLACTONE 79 54 57 72
AMOXICILLIN 78 53 59 90
DIOVAN 78 47 59 51
MONTELUKAST SODIUM 75 33 61 118
DONEPEZIL HCL 75 75 61 32
METHYLPREDNISOLONE 75 43 61 119
DICLOFENAC SODIUM 75 51 61 74
WARFARIN SODIUM 75 62 61 15
DOXEPIN HCL 73 36 66 180
TRILIPIX 72 43 67 153
NAPROXEN 72 37 67 80
VYTORIN 71 35 69 169
AMOX TR-POTASSIUM CLAVULANATE 70 34 70 131
AMLODIPINE BESYLATE-BENAZEPRIL 68 68 71 77
LOSARTAN POTASSIUM 63 30 72 29
ISOSORBIDE DINITRATE 62 31 73 232
FLUTICASONE PROPIONATE 61 38 74 38
ALENDRONATE SODIUM 61 46 74 41
PREDNISONE 61 46 74 40
LANSOPRAZOLE 60 22 77 102
BUMETANIDE 60 40 77 123
LIDODERM 59 46 79 140
VOLTAREN 59 36 79 265
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 40 81 88
LEVOFLOXACIN 56 36 82 71
COREG CR 56 29 82 339
SPIRIVA 55 43 84 57
THEOPHYLLINE ANHYDROUS 53 30 85 158
ENALAPRIL MALEATE 52 12 86 98
TRAZODONE HCL 51 30 87 33
ONGLYZA 51 47 87 205
GLIMEPIRIDE 51 24 87 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.